Protocadherin-7 contributes to maintenance of bone homeostasis through regulation of osteoclast multinucleation.
Journal
BMB reports
ISSN: 1976-670X
Titre abrégé: BMB Rep
Pays: Korea (South)
ID NLM: 101465334
Informations de publication
Date de publication:
Sep 2020
Sep 2020
Historique:
received:
06
03
2020
pubmed:
9
7
2020
medline:
3
7
2021
entrez:
9
7
2020
Statut:
ppublish
Résumé
Osteoclasts are hematopoietic-derived cells that resorb bone. They are required to maintain proper bone homeostasis and skeletal strength. Although osteoclast differentiation depends on receptor activator of NF-κB ligand (RANKL) stimulation, additional molecules further contribute to osteoclast maturation. Here, we demonstrate that protocadherin-7 (Pcdh7) regulates formation of multinucleated osteoclasts and contributes to maintenance of bone homeostasis. We found that Pcdh7 expression is induced by RANKL stimulation, and that RNAi-mediated knockdown of Pcdh7 resulted in impaired formation of osteoclasts. We generated Pcdh7-deficient mice and found increased bone mass due to decreased bone resorption but without any defect in bone formation. Using an in vitro culture system, it was revealed that formation of multinucleated osteoclasts is impaired in Pcdh7-deficient cultures, while no apparent defects were observed in differentiation and function of Pcdh7-deficient osteoblasts. Taken together, these results reveal an osteoclast cell-intrinsic role for Pcdh7 in maintaining bone homeostasis. [BMB Reports 2020; 53(9): 472-477].
Substances chimiques
Cadherins
0
PCDH7 protein, mouse
0
Protocadherins
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
472-477Subventions
Organisme : NIAMS NIH HHS
ID : R01 AR077526
Pays : United States
Références
Bone. 2011 Apr 1;48(4):677-92
pubmed: 21145999
Nature. 2003 May 15;423(6937):337-42
pubmed: 12748652
Curr Biol. 1998 Mar 12;8(6):325-34
pubmed: 9512415
Dev Cell. 2003 Mar;4(3):419-29
pubmed: 12636922
Cell Mol Life Sci. 2017 Nov;74(22):4133-4157
pubmed: 28631008
Nat Rev Mol Cell Biol. 2014 Jun;15(6):397-410
pubmed: 24824068
Acta Biomater. 2018 Jun;73:488-499
pubmed: 29656074
Sci Transl Med. 2014 Mar 26;6(229):229ra40
pubmed: 24670684
Nat Rev Genet. 2003 Aug;4(8):638-49
pubmed: 12897775
Annu Rev Cell Dev Biol. 2014;30:291-315
pubmed: 25062360
Arch Biochem Biophys. 2008 May 15;473(2):201-9
pubmed: 18406338
Trends Cell Biol. 2007 Nov;17(11):537-46
pubmed: 17981036
J Cell Sci. 2015 Apr 15;128(8):1455-64
pubmed: 25749861
Cell Mol Life Sci. 2005 Jun;62(11):1247-59
pubmed: 15905963
Trends Genet. 2013 Jul;29(7):427-37
pubmed: 23453622
Biochem Biophys Res Commun. 2014 Dec 12;455(3-4):305-11
pubmed: 25446128
Prog Mol Biol Transl Sci. 2013;116:169-92
pubmed: 23481195
Nat Rev Immunol. 2007 Apr;7(4):292-304
pubmed: 17380158
Nat Med. 2007 Jul;13(7):791-801
pubmed: 17618270
Trends Cell Biol. 2009 Oct;19(10):514-22
pubmed: 19733078
Cancer Res. 2017 Jan 1;77(1):187-197
pubmed: 27821484
Bone Res. 2020 Feb 10;8:5
pubmed: 32047704
Sci Rep. 2017 Mar 15;7(1):196
pubmed: 28298636
Cell Adh Migr. 2011 Mar-Apr;5(2):97-105
pubmed: 21173574
Immunol Invest. 2013;42(7):555-622
pubmed: 24004059
Annu Rev Immunol. 2006;24:33-63
pubmed: 16551243
Patient Prefer Adherence. 2014 Apr 08;8:463-71
pubmed: 24748775